Close

BIO 2000 Opening Plenary Speech / Boston

We meet here in Boston at a truly remarkable moment in the relatively short but dramatic history of the biotechnology industry.

Testimony on the Proposed Rule on Confidentiality of Patient Records

Regarding the Proposed Rule on Confidentiality of Patient Records Could Impede Research before the Senate Health, Education, Labor and Pensions Committee.

Testimony of Michael J. Werner, Esq.

On behalf of the Biotechnology Industry Organization (BIO), regarding the Proposal That Calls For A Moratorium on Some Human Gene Therapy Protocols before the NIH Recombinant DNA Advisory Committee.

Comments on Proposed Standards for Privacy of Individually Identifiable Health Information

Addressed to Margaret Ann Hamburg, M.D., Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services.

Testimony of H. Stewart Parker

On behalf of the Biotechnology Industry Organization (BIO), on oversight of gene therapy before the U.S. Senate Health, Education, Labor and Pensions Subcommittee on Public Health.

Comments submitted to Secretary's Advisory Committee on Genetic Testing in response to the public consultation

On Genetic Testing in response to the public consultation.

BIO's statement regarding reform of Hatch-Waxman Law

The Biotechnology Industry Organization (BIO) supports reforms of the Hatch Waxman Act that will provide full day-for-day restoration of lost patent term for drugs which require extended reviews and/or clinical trials for FDA approval.

Statement regarding confidentiality of patient medical records

Submitted to the Subcommittee on Health and the Environment House Commerce Committee

BIO's testimony on patent reform to maximize innovation in the biotechnology industry

BIO supports amendments to the patent law that, above all, ensure that diligent patent applicants are not penalized for delays which are beyond their control.

BIO Response to NBAC on Stem Cell Research

BIO appreciates the NBAC's leadership in analyzing the potential benefits and the ethical implications of research on stem cells and we thank you for this opportunity to comment.